Application | Ubigene

Application

All (274)
Case Study (63)
Expert Insights - Cell Culture (23)
Expert Insights - Cell Application (44)
Expert Insights - CRISPR Library (51)
Gene Editing Practical Tips (31)
Others (62)

Rapid mRNA Delivery Supported by Ubigene 293T-EGFP Cells

Read how Prof. Bin Li's team developed a novel MrLNP platform for rapid mRNA delivery (33-fold in vivo efficiency increase). Ubigene's stable 293T-EGFP cell line supported this study to validate CRISPR-Cas9 genome editing and gene knockout efficiency.

Glucocorticoid Receptor Acts as the Switch for DTC Immune Evasion in TNBC

Discover how the GR-FAS axis controls DTC immune evasion during metastatic seeding in Nature. Ubigene provides reliable RELA knockout cell lines to accelerate your cancer research.

Comprehensive Guide to Point Mutation Cell Line Construction via RNP Method

Discover how to optimize point mutation cell line construction using Cas9 RNP & HDR. Learn key strategies to boost HDR efficiency up to 84% with Ubigene.

New Tumor Suppressor ECHS1 Found in Early HCC

A recent Cancer Cell study reveals how TERT mutations initiate HCC and CNAs drive early malignant transition from dysplastic nodules, identifying ECHS1 as a novel tumor suppressor.

CRISPR Screening: KLHL6 as a Switch for T Cell Immunotherapy

Identify how CRISPR screening discovered KLHL6 as a dual regulator of T cell exhaustion and mitochondrial function. Explore Ubigene's CRISPR-iScreen™ library services for breakthrough oncology research.